• London

    Iain Miller, EPEMED board member, and Jorge Mestre-Ferrandiz, OHE Director of Consulting, will co-present the methodology and results of the OHE EPEMED 2016 study, "Value of Knowing and Knowing of Value: the need for an expanded value framework for complementary diagnostics”, on the 12th of Sep 16 from 17:55 to18:25 GMT.
  • London

    Iain Miller will attend and moderate on July 12th the session “The Critical role of Biomarkers and Companion Diagnostics Development”. For more information, email at contact@epemed.org.
  • -

    Brussels

    Emmanuelle Benzimra, Executive Director, will be attending the conference. Contact her at contact@epemed.org
  • -

    London

    Alain Huriez, EPEMED President, will chair the EASL-EPEMED Joint Workshop "Personalised Biomarkers in liver disease” in London on April 9th / 08:00-11:00am
    Download file (1.17 MB)
  • -

    London

    Emmanuelle Benzimra, Executive Director, will be attending the conference. Contact her at contact@epemed.org.
  • Silicon Valley

    Mara Aspinall, EPEMED vice-president, will introduce the preliminary results and methodology of the OHE EPEMED 2015 study, “HTA of complementary diagnostics : issues, options and opportunities”, at the PMWC conference, on the 25th of Jan 16, in Silicon Valley, track 4 (Personalised Medicine and Diagnostics Beyond the USA)
  • London

    Alain Huriez, EPEMED President, will be a panelist on the session “Changing the face of cancer care - the impacts of personalised medicine on diagnostics and treatments”
  • Luxembourg

    Emmanuelle Benzimra, EPEMED General Delegate will chair the session « adressing known obstacles to integrating PM into health systems ».
  • -

    London

    Personalized Medicine & Cancer Biomarker

    Iain Miller, EPEMED board member and Secretary, will share as a speaker insight over oncology, personalised medicine and biomarkers

  • -

    Cambridge

    Personalised Medicine 2015

    Iain Miller, EPEMED board member and Secretary, will chair the afternoon sessions

  • -

    Lille

    Quel modèle économique pour la médecine personnalisée ?

    Pablo Jordan, EPEMED Board Member, will be a panelist on the third session : "Les comparaisons avec des modèles économiques européens".

  • -

    Oxford

    Personalized Medicine World Conference

    Emmanuelle Benzimra, EPEMED General Delegate, will attend as a partner of the conference in Oxford

  • Paying for Personalised Medicine and Implementation in Patient Care

    >>>Read more

    Access a replay of the EPEMED sessions
    >>> Watch videos

  • -

    Dublin

    EPEMED chairs the workgroup "Education, let's start again: requirements to fix undeveloped PM education structures" on October 21st from 14.30 to 17.30.
  • -

    Basel

    Alain Huriez will co-chair therapeutic panel "Personalised Medicine & Diagnostics on September 30th
  • -

    Madrid

    Invitation-Only roundtable: Closing the Gaps in Personalised Medicine for Lung Cancer
    EPEMED is a panelist at the Pfizer Oncology half-day roundtable on September 29, 2014 from 1 PM to 4 PM during the European Cancer Congress (ECCO/ESMO) in Madrid, Spain

  • -

    Tallinn

    EPEMED is part of EuroBioForum Scoping Session ‘Education & Training’ in Personalised Medicine on September 23rd.
  • -

    San Diego

    EPEMED will be present at the BIO International Convention - the largest global event for the biotech industry - from 23-26 June 2014 in San Diego, US. Alain Huriez, EPEMED President, will be chairing the roundtable “Making Personalized Medicine a Global Reality for Everyone, Anywhere, Anytime”, Thursday 26/06, 2:15 PM to 3:30 PM, Room 7AB San Diego Convention Center.

    A session hosted by FlandersBio, the networking organisation for the life sciences sector in Flanders - Belgium, and Flanders Investment & Trade, featuring:
    Iain Miller (Healthcare Strategies Group and EPEMED member), Rudi Pauwels (Biocartis), Werner Verbiest (Janssen Diagnostics and EPEMED member)
    • Success stories on how to overcome the challenges when engaging in
    personalised medicine
    • New business models that speed up the global implementation of personalised
    medicine
    • A discussion on value-based pricing and reimbursement of diagnostic tests in
    both the US and Europe

    >>>Website

  • -

    London

    Peter Collins, EPEMED Board Member, will chair the morning session DAY 1 Stream 1 "strategies to enable successful implementation of Precision Medicine". Emmanuelle Benzimra, EPEMED General Delegate, will attend the conference.

    >>>Website

  • -

    London

    Iain Miller, EPEMED board member and Secretary, will chair the panel ” Will companion Dx exist in 2020? “The transition from single CDx paradigms to multi-omic testing”, London on May 13th / 13:30-14:20

    >>> Website

    Download file (488.44 kB)
  • -

    Frankfurt

    Iain Miller, EPEMED Board Member and Secretary, will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”, on April 23rd / 03:00-03:30pm

    >>> Website

  • -

    Berlin

    Dr. Stefan N. Willich, MPH MBA, Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin and Emmanuelle Benzimra, EPEMED General Delegate, will both attend workshop.

    >>> Website

  • -

    Vienna

    Markus Bücheler, MD, Institute for Social Medicine, Epidemiology, and Health Economics Charité - Universitätsmedizin Berlin, will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”

    >>> Website

  • -

    Köln

    Prof. Dr. med. Bernd Brüggenjürgen, coordinator for Health Systems Research at the Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, will be a discussion partner of the "patient benefit vs. cost containment, how to measure the value of innovation?" on the 21.3.14.

    >>> Website

  • Berlin

    Prof. Dr. med. Bernd Brüggenjürgen, coordinator for Health Systems Research at the Institute for Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin , will speak about the EPEMED La Charité Patient Access Study 2012-2013 “Personalised Medicine in Europe: enhancing patient access to drug-diagnostic companion products”

    >>> Website